Inmed Pharmaceuticals Inc. · NASDAQ:INM
Schneeberger Daniel bought 91,101 Inmed Pharmaceuticals Inc. shares (Form 4)
Traded Sep 14 to Sep 16, 2026 · Filed Sep 16, 2026
From Sep 14 to Sep 16, 2026, Schneeberger Daniel (10% owner) bought 91,101 Inmed Pharmaceuticals Inc. shares at an average US$1.30 for US$118K, leaving 892,101 shares. Filed Sep 16, 2026 (Form 4).
- Bought
- 91,101 shares
- Price
- US$1.30 average (US$1.29 to US$1.30)
- Value
- US$118K
- Holding after
- 892,101 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Shares | Buy | 28,505 | US$1.29 | 829,505 | Indirect |
| Sep 15, 2026 | Common Shares | Buy | 54,256 | US$1.30 | 883,761 | Indirect |
| Sep 16, 2026 | Common Shares | Buy | 8,340 | US$1.29 | 892,101 | Indirect |
Source
Related
- Inmed Pharmaceuticals Inc.
- Schneeberger Daniel
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · Schneeberger Daniel · May 21, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 20, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026